Objective:To explore the effect of Traditional Chinese Medicine (TCM) syndrome differentiation and nursing on quality of life and immune function of elderly patients with middle and advanced non-small cell lung cancer.Methods:A total of 95 elderly patients with non-small cell lung cancer who were admitted to Taizhou Hospital of Zhejiang Province from March to April 2019 were selected by convenience sampling. Among them, 46 patients admitted from March to September 2018 were selected as the control group and 49 patients admitted from October 2018 to April 2019 were selected as the observation group. Patients in the control group were given routine nursing, while patients in the observation group were given TCM syndrome differentiation and nursing on the basis of control group. The the MOS Item Short from Health Survey (SF-36) score, T lymphocyte subsets and nursing satisfaction of patients before and after intervention were compared between the two groups.Results:After the intervention, SF-36 scores of patients of the two groups were lower than those before the intervention ( P<0.05) , and the SF-36 scores of the observation group after the intervention were significantly higher than those of the control group, the differences were statistically significant ( P<0.05) . After the intervention, levels of CD3 +, CD4 + and CD4 +/CD8 + in the two groups were lower than before the intervention ( P<0.05) , and the levels of CD3 +, CD4 + and CD4 +/CD8 + in the observation group after intervention were higher than those in the control group, the differences were statistically significant ( P<0.05) . The nursing satisfaction of the observation group was significantly higher than that of the control group, the difference was statistically significant ( P<0.05) . Conclusions:TCM syndrome differentiation and nursing is helpful to protect the quality of life and immune function of elderly patients with middle and advanced non-small cell lung cancer undergoing chemotherapy and improve nursing satisfaction of patients, which is worthy of clinical promotion.

Transportation service is an important part of hospital logistics management. In 2023, a tertiary hospital centered on patient service and guided by lean management, launched an intelligent transportation service in the " Didi" mode on the basis of the medical internet of things platform. This practice investigated the status of hospital transportation services and developed an intelligent transportation system that includes three subsystems: task reception and generation, dispatch and command of transportation center, and handheld computer accepting order. At the same time, standardized business processes were developed and transportation service performance evaluations were implemented. This practice had gradually piloted and achieved intelligent management of hospital transportation services. As of December 2023, the hospital had completed a total of about 310 thousand transportation tasks, of which 70% were intelligent system dispatching tasks. The timely delivery service rate had increased from 58% in 2022 to 98% in 2023. This practice had improved the quality and efficiency of transportation services, promoted the high-quality development of hospital logistics management, which could provide references for other hospitals to improve logistics management efficiency.

Objective? To investigate the risks of malnutrition in patients with lung cancer during chemotherapy and to analyze their influencing factors. Methods? The inpatients with lung cancer receiving chemotherapy in the Department of Respiratory Medicine, Enze Medical Center from September 2017 to August 2018 were selected by convenient sampling. The 112 patients were divided into groups according to Nutrition Risk Screen (NRS) 2002. Their general information, diet and malnutrition risks were investigated successively. Logistic regression analysis was used to identify the influencing factors to malnutrition risks of the patients during chemotherapy. Results? Totally 112 patients completed the study. 28 of them showed no risk of malnutrition, while 84 had risks of malnutrition. There were statistically significant differences in age, place of residency, household monthly income, nutritional management, tumor staging, intake of protein and fat, nausea, emesis and diarrhea between two groups with different nutrition conditions(P＜ 0.01). Logistic regression analysis revealed that age, place of residency,monthly income, nutritional management, tumor staging, intake of protein, nausea, emesis and diarrhea were the risk factors of malnutrition in patients with lung cancer during chemotherapy. Conclusions? Patients with lung cancer are at high risk of malnutrition during chemotherapy. Age, nutritional management, tumor staging, intake of protein, nausea, emesis and diarrhea are the risk factors of malnutrition in patients during chemotherapy. Effective nutritional management intervention shall be made for patients as early as possible, so as to reduce the incidence and worsening of malnutrition and improve patients' effects and quality of life.